Search

everythinglearnresearchcommunity

for

Search:↓

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Finasteride may lower cholesterol and slow heart disease progression.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Finasteride remains stable for two years with proper storage.

New method quickly and accurately measures finasteride in tablets.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Alcoholic solvent improves selectivity in key intermediate for finasteride and dutasteride synthesis.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

New compounds may help treat prostate cancer by reducing cell growth.

Lowering testosterone speeds up wound healing in male mice.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

New method detects finasteride in plasma quickly and accurately without clean-up.

New method accurately measures finasteride in tablets and bulk.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

The study successfully formulated and optimized a bilayer tablet combining Tamsulosin and Finasteride using response surface methodology.

Topical finasteride helps regrow hair and reduce balding without side effects.